Exposure of toll-like receptors 4 to bacterial lipopolysaccharide (LPS) impairs human colonic smooth muscle cell function

Journal of Cellular Physiology

Volumn 223, Issue 2, 2010, Pages 442-450

  Scirocco, Annunziata ^a   Matarrese, Paola ^b   Petitta, Chiara ^a   Cicenia, Alessia ^a   Ascione, Barbara ^b   Mannironi, Cecilia ^c   Ammoscato, Francesca ^a   Cardi, Maurizio ^a   Fanello, Gianfranco ^a   Guarino, Michele P L ^d   Malorni, Walter ^b   Severi, Carola ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^c CNR   (Italy)

^d UNIVERSITY CAMPUS BIO MEDICO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

APOCYNIN; BACTERIUM LIPOPOLYSACCHARIDE; BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; ENDOTOXIN; GLUTATHIONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN MD 2; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4;

ARTICLE; COLON; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOSKELETON; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERPOLARIZATION; INTESTINE MUSCLE; MICROFILAMENT; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SMOOTH MUSCLE CONTRACTILITY;

CELLS, CULTURED; COLITIS; COLON; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTOXEMIA; GASTROINTESTINAL MOTILITY; HUMANS; ILEUS; INFLAMMATION MEDIATORS; LIPOPOLYSACCHARIDES; LYMPHOCYTE ANTIGEN 96; MEMBRANE POTENTIAL, MITOCHONDRIAL; MUSCLE CONTRACTION; MYOCYTES, SMOOTH MUSCLE; OXIDATIVE STRESS; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4;

BACTERIA (MICROORGANISMS);

EID: 77950856356     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.22053     Document Type: Article

References (48)

1. Akira S. 2003. Mammalian Toll-like receptors. Curr Opin Immunol 15:5-11.
2. Akira S, Takeda K, Kaisho T. 2001. Toll-like receptors: Critical proteins linking innate and acquired immunity. Nat Immunol 2:675-680. (Pubitemid 32747155)
3. Barbara G, Stanghellini V, Brandi G, Cremon C, Di Nardo G, De Giorgio R, Corinaldesi R. 2005. Interactions between commensal bacteria and gut sensorimotor function in health and disease. Am J Gastroenterol 100:2560-2568.
4. Böcker U, Yezerskyy O, Feick P, Manigold T, Panja A, Kalina U, Herweck F, Rossol S, Singer MV. 2003. Responsiveness of intestinal epithelial cell lines to lipopolysaccharide is correlated with Toll-like receptor 4 but not Toll-like receptor 2 or CD14 expression. Int J Colorectal Dis 18:25-32.
5. Cario E, Gerken G, Podolsky DK. 2007. Toll-like receptor 2 controls mucosal inflammation by regulating epithelial barrier function. Gastroenterology 132:1359-1374. (Pubitemid 46627595)
6. Carton Y, Nappi AJ. 2001. Immunogenetic aspects of the cellular immune response of Drosophila against parasitoids. Immunogenetics 52:157-164. (Pubitemid 32142802)
7. Danenberg HD, Welt FG, Walker M, Seifert P, Toegel GS, Edelman ER. 2002. Systemic inflammation induced by lipopolysaccharide increases neointimal formation after balloon and stent injury in rabbits. Circulation 105:2917-2922. (Pubitemid 34666108)
8. Dobrovolskaia MA, Medvedev AE, Thomas KE, Cuesta N, Toshchakov V, Ren T, Cody MJ, Michalek SM, Rice NR, Vogel SN. 2003. Induction of in vitro reprogramming by Toll-like receptor (TLR)2 and TLR4 agonists in murine macrophages: Effects of TLR "homotolerance" versus "heterotolerance" on NF-kappa B signaling pathway components. J Immunol 170:508-519.
9. Edfeldt K, Swedenborg J, Hansson GK, Yan ZQ. 2002. Expression of toll-like receptors in human atherosclerotic lesions: A possible pathway for plaque activation. Circulation 105:1158-1161. (Pubitemid 34225814)
10. Erridge C, Burdess A, Jackson AJ, Murray C, Riggio M, Lappin D, Milligan S, Spickett CM, Webb DJ. 2008. Vascular cell responsiveness to Toll-like receptor ligands in carotid atheroma. Eur J Clin Invest 38:713-720.
11. Eskandari MK, Kalff JC, Billiar TR, Lee KK, Bauer AJ. 1999. LPS-induced muscularis macrophage nitric oxide suppresses rat jejunal circular muscle activity. Am J Physiol 277:478-486.
12. Feng-Yen L, Yung-Hsiang C, Jen-Sung T, Jaw-Wen C, Tung-Lin Y, Hsiao-Jung W, Chi-Yuan L, Yuh-Lien C, Shing-Jong L. 2006. Endotoxin induces toll-like receptors 4 expression in vascular smooth muscle cells via NADPH oxidase activation and mitogen-activated protein kinase signalling pathways. Aterioscler Thromb Vasc Biol 26:2630-2637.
13. Ferri KF, Kroemer G. 2001. Organelle-specific initiation of cell death pathways. Nat Cell Biol 3:255-263. (Pubitemid 34428737)
14. Frantz S, Kobnik L, Kim YD, Fukazawa R, Medhizov R, Lee RT, Kelly RA. 1999. Toll 4 (TLR4) expression in cardiac myocytes in normal and failing myocardium. J Clin Invest 104:371-380.
15. Frey T. 1997. Correlated flow cytometric analysis of terminal events in apoptosis reveals the absence of some changes in some model systems. Cytometry 28:253-263. (Pubitemid 27294714)
16. Guarino MP, Altomare A, Stasi E, Marignani M, Severi C, Alloni R, Dicuonzo G, Morelli L, Coppola R, Cicala M. 2008. Effect of acute mucosal exposure to Lactobacillus rhamnosus GG on human colonic smooth muscle cells. J Clin Gastroenterol 42:185-190.
17. Hooper LV, Wong MH, Thelin A, Hansson L, Falk PG, Gordon JI. 2001. Molecular analysis of commensal host-microbial relationships in the intestine. Science 2:881-884. (Pubitemid 32120760)
18. Jimenez R, Belcher E, Sriskandan S, Lucas R, McMaster S, Vojnovic I, Warner TD, Jane MA. 2005. Role of Toll-like receptors 2 and 4 in the induction of cyclooxygenase-2 in vascular smooth muscle. Proc Natl Acad Sci USA 22:4637-4642. (Pubitemid 40397164)
19. Lee DH, Goldberg AL. 1998. Proteasome inhibitors: Valuable new tools for cell biologists. Trends Cell Biol 8:397-403.
20. Louvet-Vallee S. 2000. ERM proteins: From cellular architecture to cell signaling. Biol Cell 92:305-316.
21. Matsuyama S, Llopis J, Deveraux QL, Tsien RY, Reed JC. 2000. Changes in intramitochondrial and cytosolic pH: Early events that modulate caspase activation during apoptosis. Nat Cell Biol 2:318-325.
22. Nagai Y, Akashi S, Nagafuku M, Ogata M, Iwakura Y, Akira S, Kitamura T, Kosugi A, Kimoto M, Miyake K. 2002. Essential role of MD-2 in LPS responsiveness and TLR4 distribution. Nat Immunol 3:667-672. (Pubitemid 34752476)
23. Neal KR, Hebden J, Spiller R. 1997. Prevalence of gastrointestinal symptoms six months after bacterial gastroenteritis and risk factors for development of the irritable bowel syndrome: Postal survey of patients. Br Med J 314:779-782. (Pubitemid 27117047)
24. Neish AS. 2009. Microbes in gastrointestinal health and disease. Gastroenterology 136:65-80.
25. Nimnual AS, Taylor LJ, Bar-Sagi D. 2003. Redox-dependent downregulation of Rho by Rac. Nat Cell Biol 5:236-241.
26. O'Neill LA. 2003. Therapeutic targeting of Toll-like receptors for inflammatory and infectious diseases. Curr Opin Pharmacol 3:396-403.
27. Perl A, Gergely P, Jr., Nagy G, Koncz A, Banki K. 2004. Mitochondrial hyperpolarization: A checkpoint of T-cell life, death and autoimmunity. Trends Immunol 25:360-367. (Pubitemid 38780952)
28. Rebollar E, Arruebo MP, Plaza MA, Murillo MD. 2002. Effect of lipopolysaccharide on rabbit small intestine muscle contractility in vitro: Role of prostaglandins. Neurogastroenterol Motil 14:633-642.
29. Rensen SS, Doevendans PA, van Eys GJ. 2007. Regulation and characteristics of vascular smooth muscle cell phenotypic diversity. Neth Heart J 15:100-108.
30. Riganti C, Costamagna C, Doublier S, Miraglia E, Polimeni M, Bosia A, Ghigo D. 2008. The NADPH oxidase inhibitor apocynin induces nitric oxide synthesis via oxidative stress. Toxicol Appl Pharmacol 228:277-285.
31. Rock FL, Hardimann G, Timans JC, Kastelein RA, Bazan JF. 1998. A family of human receptors structurally related to Drosophila Toll. Proc Natl Acad Sci USA 95:588-593.
32. Rumio C, Besusso D, Arnaboldi F, Palazzo M, Selleri S, Gariboldi S, Akira S, Uematsu S, Bignami P, Ceriani V, Ménard S, Balsari A. 2006. Activation of smooth muscle and myenteric plexus cells of jejunum via Toll-like receptor 4. J Cell Physiol 208:47-54.
33. Sanlioglu S, Williams CM, Samavati L, Butler NS, Wang G, McCray PB Jr, Ritchie TC, Hunninghake GW, Zandi E, Engelhardt JF. 2001. Lipopolysaccharide induces Rac1-dependent reactive oxygen species formation and coordinates tumor necrosis factor-alpha secretion through IKK regulation of NF-kappa B. J Biol Chem 276:30188-30198.
34. Sarkar A, Goutam M, Neeloo S, Shyam S, Mitali C. 2009. Flow cytometric determination of intracellular non-protein thiols in Leishmania promastigotes using 5-chloromethyl fluorescin diacetate. Exp Parasitol 122:299-305.
35. Schromm AB, Lien E, Henneke P, Chow JC, Yoshimura A, Heine H, Latz E, Monks BG, Schwartz DA, Miyake K, Golenbock DT. 2001. Molecular genetic analysis of an endotoxin nonresponder mutant cell line: A point mutation in a conserved region of MD-2 abolishes endotoxin-induced signaling. J Exp Med 194:79-88.
36. Sebastia J, Cristofol R, Martin M, Rodriguez-Farre E, Sanfeliu C. 2003. Evaluation of fluorescent dyes for measuring intracellular glutathione content in primary cultures of human neurons and neuroblastoma SH-SY5Y. Cytometry 51:16-25.
37. Shan X, Hu A, Veler H, Fatma S, Grunstein JS, Chuang S, Grunstein MM. 2006. Regulation of Toll-like receptor 4-induced proasthmatic changes in airway smooth muscle function by opposing actions of ERK1/2 and p38 MAPK signaling. Am J Physiol Lung Cell Mol Physiol 291:324-333.
38. Shi XZ, Lindholm P, Sarna SK. 2003. NF-kB activation by oxidative stress and inflammation suppresses contractility in colonic circular smooth muscle cells. Gastroenterology 124:1369-1380.
39. Spates ST, Cullen JJ, Ephgrave KS, Hinkhouse MM. 1998. Effect of endotoxin on canine colonic motility and transit. J Gastrointest Surg 2:391-398.
40. Spiller R, Garsed K. 2009. Postinfectious irritable bowel syndrome. Gastroenterology 136:1979-1988.
41. Sukkar MB, Xie S, Khorasani NM, Kon OM, Stanbridge R, Issa R, Chung KF. 2006. Toll-like receptor 2, 3, and 4 expression and function in human airway smooth muscle. J Allergy Clin Immunol 118:641-648.
42. Tattoli I, Corleto VD, Taffuri M, Campanini N, Rindi G, Caprilli R, Delle Fave G, Severi C. 2004. Optimisation of isolation of richly pure and homogeneous primary human colonic smooth muscle cells. Dig Liver Dis 36:735-743.
43. Testro AG, Visvanathan K. 2006. Toll-like receptors and their role in gastrointestinal disease. J Gastroenterol Hepatol 24:943-954.
44. Vink A, Schoneveld AH, van der Meer JJ, van Middelaar BJ, Sluijter JP, Smeets MB, Quax PH, Lim SK, Borst C, Pasterkamp G, de Kleijn DP. 2002. In vivo evidence for a role of toll-like receptor 4 in the development of intimal lesions. Circulation 106:1985-1990.
45. Wright S, Ramos RA, Tobias PS, Ulevitch RJ, Mathison JC. 1990. CD14, a receptor for complexes of LPS and LPS/binding protein. Science 249:1431-1433.
46. Yang X, Coriolan D, Murthy V, Schultz K, Golenbock DT, Beasley D. 2005a. Proinflammatory phenotype of vascular smooth muscle cells: Role of efficient Toll-like receptor 4 signalling. Am J Physiol Heart Circ Physiol 289:1069-1076.
47. Yang X, Coriolan D, Schultz K, Douglas T, Golenbock Beasley D. 2005b. Toll-like receptor 2 mediates persistent chemokine release by Chlamydia pneumoniae-infected vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 25:2308-2314.
48. Yoshinori N, Sachiko A, Masakazu N, Masato O, Yoichiro I, Shizuo A, Toshio K, Atsushi K, Masao K, Kensuke M. 2002. Essential role of MD-2 in LPS responsiveness and TLR4 distribution. Nat Immunol 3:667-672.